ArticleItalian journal of pediatrics2025
Long-term cardiometabolic and bone health consequences of ketogenic diet in children with refractory epilepsy.
Article in Italian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKetogenic diet (KD) is a well-tolerated and efficacious therapy for refractory epilepsy (RE). While numerous mild short-term side effects have been reported, long-term cardiometabolic and bone heath consequences of KD need more advanced work-up and were not fully evaluated especially in children. So, we aimed to evaluate cardiac, vascular, metabolic, bone health and growth consequences in children with RE receiving KD for more than 2 years compared to those receiving antiepileptic drugs (AEDs ) without any dietary interference. METHODES: Fifty-six children following KD for at least 2 years, 27 classic KD and 29 modified atkins diet (MAD), were recruited in addition to 40 children with RE maintained on multiple AEDs. Lipid profile values, atherogenic indices, serum selenium binding protein 1, and anthropometric measurements were measured for all participants. Additionally, echocardiography, electrocardiography, carotid ultrasonography and DEXA scan were performed.
resultsAtherogenic index of plasma (AIP) was high in all groups with no significant correlation with carotid intima-media thickness. Although no cardiac complications were documented, Bone mineral density (BMD) was significantly reduced in all groups. Castelli risk index II and ambulation were the significant predictors for reduced BMD in KD groups in contrast to AIP in AEDs group. Stunted growth was most prevalent in MAD group 44.8% while wasting was highest in AEDs group 40%.
conclusionsKD did not show additional risk regarding metabolic, cardiovascular, BMD and growth side effects compared to AEDs only. Therefore, KD remains a relatively safe dietary therapy for RE, yet close monitoring is still recommended.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.